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Abstract
Persistent mating-induced endometritis (PMIE) is a significant cause of mare infertility hence its treatment
would advance the management of susceptible mares. Preimplantation factor (PIF) is secreted by viable
embryos, including human, mouse and cattle, and is essential for maternal immune-tolerance without immune-
suppression by modulating inflammation. This preliminary study aimed to test whether PIF exerts inflamma-
tory-modulating properties upon equine endometrium challenged with Escherichia coli-derived lipopolysaccha-
ride (LPS) using endometrial explant culture. Follicular (n = 3), luteal (n = 4), anoestrous (n = 4) and
transitional (n = 4) stage endometrial explants were established and cultured in triplicate in either serum-free
medium alone (control) or medium with; 50 or 100 nmol/L synthetic PIF (sPIF); 3 lg/mL LPS; LPS and 50 or
100 nmol/L sPIF; or scrambled PIF (PIFscr; same amino acid composition arranged in a different order).
Media samples were collected at 24 and 72 h, representing acute and chronic inflammatory response. Radioim-
munoassay determined Prostaglandin F2a (PGF2a) as an inflammatory marker. The only significant observation
was the abrogation of PGF2a response to LPS challenge by 100 nmol/L PIF for follicular stage tissue, 24 h after
treatment. Further studies are therefore, warranted to realise PIF potential in managing PMIE.
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Introduction
In mares, the acute but transient, mating-induced
uterine inflammation (MIE) observed after insemi-
nation is a ubiquitous innate immune response to
semen and/or bacteria (Allen & Pycock 1989; Katila
2001; LeBlanc 2010). Bacteria are frequently recov-
ered from the uterus after mating; particularly, Strep-
tococcus zooepidemicus and Escherichia coli
(Hughes & Loy 1975; Wingfield Digby & Ricketts
1982) and bacterial antigens stimulate an innate
immune response (Christoffersen & Troedsson
2017). However, in up to 40% of mares, inflamma-
tion persists (persistent mating-induced endometritis;
PMIE) causing embryonic loss (Pycock & New-
combe 1996). In practice, treatment may only com-
mence after PMIE is established (LeBlanc 2010),
therefore there is interest in agents which may
modulate the innate immune response before inflam-
mation becomes established. Steroids, Mycobac-
terium cell wall extract and N-acetylcysteine have
shown potential (Fumuso et al. 2007; Bucca et al.
2008; Gores-Lindholm et al. 2013; Melkus et al.
2013); however, with each there are important draw-
backs (LeBlanc 2010; Gores-Lindholm et al. 2013;
Woodward et al. 2015). Therefore, a need exists to
discover novel anti-inflammatories which may com-
plement the innate immune response.
Preimplantation factor (PIF) is a protein secreted
exclusively by viable embryos shortly after fertilisa-
tion, inducing maternal acceptance through immune
tolerance without maternal immune-suppression
(Barnea 2004; Paidas et al. 2010; Stamatkin et al.
2011). PIF exerts its immune function on the mater-
nal system directly on endometrial and immune cells;
PIF up-regulates human decidual cell genes
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including interleukin 6 (IL-6) and IL-1b and changes
expression at the protein level (Paidas et al. 2010).
Due to its immune-modulatory function, PIF is
therefore a potential novel anti-inflammatory.
An optimised and validated tissue explant culture
system using equine endometrium provides an exem-
plar for bacteria-induced MIE (Nash et al. 2008).
Explants respond to E. coli-derived lipopolysaccha-
ride (LPS) challenge by secreting the inflammatory
marker prostaglandin F2a (PGF2a) similarly to the
whole animal and is integral to physiological repro-
ductive function as well as inflammation (Nash et al.
2008, 2010).
The aim of this preliminary study was to determine
the effect of synthetic PIF (sPIF) on the innate
immune response to LPS challenge using equine
endometrial explants collected from mares at differ-
ent stages of the oestrous cycle, using PGF2a as the
inflammatory marker.
Materials and methods
All experiments used uteri from mares sent to
slaughter at a commercial abattoir for reasons unre-
lated to the study. Therefore, ethics approval was not
required.
Strips of endometrium were collected from 17
slaughtered mares post-mortem (aged 10.3 years
1.25) at follicular (n = 3), luteal (n = 6), anoe-
strous (n = 4) and transition (n = 4) stages of cycle,
assessed as previously described (Nash et al. 2008).
Uteri were harvested from mares presented at a
commercial abattoir for reasons unrelated to this
study. Uteri were placed on ice and transported to
the laboratory. The uterine body was opened with a
scalpel and the endometrium dissected from underly-
ing myometrium using sterile scissors and forceps.
Strips were chopped to 1 mm3 and washed in HBSS
(Hank’s buffered salt solution). Sterile lens tissue-
covered aluminium mesh platforms were placed into
each well of a six-well plate (Corning Costar). A
quantity of 150 mg endometrial tissue was weighed
onto each platform and 4.25 mL of supplemented
William’s medium (Sigma) added as previously
described (Nash et al. 2008). Tissues were incubated
for 24 h in a humidified atmosphere at 37°C and 5%
carbon dioxide (CO2). After 24 h, the medium was
replaced with fresh, growth factor-free medium
alone (control) or treatment medium (designated
time point 0 h). Explants from each horse were cul-
tured in triplicate for each treatment. Treatments
were: medium alone (control); 50 nmol/L sPIF;
100 nmol/L sPIF; 3.0 lg/mL LPS from E. coli strain
0111:B4 (Source Bioscience); 3.0 lg/mL LPS with
50 or 100 nmol/L sPIF; 100 nmol/L scrambled PIF
(PIFscr; same amino acid composition arranged in a
different order, routinely used as a control measure
in other published work in this field (Barnea et al.
2012; Roussev et al. 2013). Culture supernatants
were collected 24 and 72 h after treatment, repre-
senting the acute and persistent inflammatory peri-
ods respectively. The sPIF concentrations chosen
were those found to affect human endometrium in
culture (Paidas et al. 2010). Culture supernatants
were radio immunoassayed for PGF2a.
Serum progesterone concentrations were measured
from blood collected at exsanguination was measured
using a solid phase ELISA kit (Immunodiagnostic
Systems) to retrospectively confirm the stage of oes-
trous cycle as previously described (Nash et al. 2008).
Briefly, coupled with morphological assessment of
the ovarian and cervical characteristics, stage of cycle
was defined where progesterone concentrations were:
<1 ng/mL, transition and anoestrous stage; <2 ng/
mL, follicular stage; >2 ng/mL luteal stage.
PGF2a secretion by treated explants was expressed
as percentage change from control (SEM) to
account for individual mare variation. Data were
square root transformed to achieve normality. A uni-
variate general linear model was used to compare
PGF2a secretion between control and treated
explants and Dunnett’s post hoc test was used in
SPSS v22. Significance was attributed when P < 0.05.
Results
Synthetic sPIF alone and PIFscr did not stimulate
PGF2a secretion by explants from any stage of the
oestrous cycle after 24 or 72 h. After 24 h, LPS trea-
ted explants secreted significantly more PGF2a than
control tissue (follicular and luteal stages, P < 0.001;
Figs 1a and 2a). The inflammatory response to LPS
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by follicular stage explants was abrogated in the pres-
ence of 100 nmol/L sPIF at 24 h (PGF2a concentra-
tions were not significantly different to the control;
Fig. 1a). There was a significant difference between
PGF2a secreted by explants treated with LPS alone
compared to LPS and 50 nmol/L PIF (P < 0.05;
Fig. 1a). There was no effect of any treatment on
explants collected from follicular or luteal mares
after 72 h (Figs 1b and 2b), or after 24 or 72 h for
transition or anoestrous explants (data not shown).
Discussion
This preliminary study demonstrated that 100 nmol/
L sPIF abrogated PGF2a in follicular stage explants
24 h after challenge with bacterial LPS. The ability
of PIF to abrogate PGF2a during the follicular, but
not luteal, stage of the cycle is biologically important
as this is the time when mating, and therefore, bacte-
rial challenge occurs. Therefore, PIF may interact
with the native steroid milieu of endometrium;
endogenous progesterone promotes immune-sup-
pression but concentrations are low during the follic-
ular stage (Watson et al. 1987). Neither PIF alone
(either 50 or 100 nmol/L) nor PIFscr caused an
increase of PGF2a compared to controls in explants
derived from all stages of the oestrous cycle, demon-
strating that PIF itself did not inadvertently cause
inflammation, at least in terms of prostaglandin
response.
A treatment of LPS combined with PIFscr as a fur-
ther control was not included in this study. A PGF2a
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Fig. 1. Secretion of PGF2a by follicular stage equine endometrial explants treated with control (media only), 50 nmol/L PIF, 100 nmol/L sPIF,
3.0 lg/mL LPS, 3.0 lg/mL LPS with 50 or 100 nmol/L PIF or 100 nmol/L scrambled PIF (PIFscr). The PGF2a concentrations were measured (a)
24 h (acute inflammatory period) or (b) 72 h (chronic inflammatory period) after treatment. Values differ from control, *P < 0.05; **P < 0.01;
***P < 0.001. Values differ between treatments, †P < 0.05.
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response greater than the concentrations observed
for the LPS treatment alone was unlikely to be
secreted in response to an LPS-PIFscr combination
without the addition of arachidonic acid to the med-
ium. Arachidonic acid is a substrate for prostaglan-
din synthesis and has been shown in work by
colleagues to be necessary to add to culture medium
when PGF2a secretion may otherwise reach a pla-
teaux and so maximal concentrations not achieved
(Herath et al. 2006). The present study was confident
that the LPS concentrations used would not exceed
this plateaux based on previous optimisation studies
and yet would still enable an effect of LPS and in
turn its abrogation to be observed (Nash et al. 2008),
and so arachidonic acid was not necessary to achieve
the aim of this study. Furthermore, to maintain
explants in a manner that was as close to the whole
animal as possible, avoiding further medium supple-
mentation was desirable.
It is interesting that 100 nmol/L sPIF was effective
at 24 h and not 50 nmol/L. Approximately
100 nmol/L PIF is the physiological concentration
measured during normal pregnancy in women
(Duzyj et al. 2010). sPIF of either concentration was
not effective at 72 h. The medium was not replaced
after initial treatment, so PIF activity may have been
effective up to 24 h but not maintained thereafter.
PIF stability is unconfirmed in tissue culture. How-
ever, there was also no PGF2a response to LPS alone
at the chronic, 72 h time point following challenge,
which disagrees with Nash et al. (2008) where the
model was reported as functional in response to LPS
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Fig. 2. Secretion of PGF2a by luteal stage equine endometrial explants treated with control (media only), 50 nmol/L PIF, 100 nmol/L sPIF,
3.0 lg/mL LPS, 3.0 lg/mL LPS with 50 or 100 nmol/L PIF or 100 nmol/L scrambled PIF (PIFscr). The PGF2a concentrations were measured (a)
24 h (acute inflammatory period) or (b) 72 h (chronic inflammatory period) after treatment. Values differ from control, **P < 0.01;
***P < 0.001.
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up to 72 h. Additionally, LPS induced inflammation
was evident at 24 h only in follicular stage explants,
disagreeing with Nash et al. (2008) who reported an
effect only in transition mares. The disparity between
studies may be partly explained by the possibility
that the response may have finished by 72 h and that
improvements in laboratory practice since the model
was first validated and optimised have generated
data in the present study that are more representa-
tive of the whole animal response (Nash et al. 2008).
Nonetheless, PIF has demonstrated some anti-PGF2a
properties, but its wider anti-inflammatory potential
to manage PMIE in horses requires further study.
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